Viiv Healthcare UK Limited
USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).
The verdict
According to USPTO PatentsView, Viiv ranks #33,825 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.
- #33,825
- of 49,997 US assignees by volume
- 7th percentile
- by Innovation Score (20.1/100)
- 9.1
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R33825 · Foreign Corporation #33,825 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #33,825/49,997
- PHOTO-FINISH Vibes Audio
- CPC-NARROW C07D · 4 areas
- INNOV-THIN 20.1/100
- CLAIMS-PAR 9.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Vibes Audio LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Viiv’s 20.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Viiv
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Viiv Healthcare UK · this assignee 20
Viiv Healthcare UK · this assignee
20 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Viiv's Innovation Score is 20.1/100 (7th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Viiv?
Each dot is one of Viiv’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Viiv’s own 9.1 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Viiv's grants concentrate
Viiv Healthcare UK Limited is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2016. By volume, Viiv sits between Vibes Audio LLC and Vision Motor Sports, Inc..
Who files at Viiv's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Vibes Audio
Vibes Audio LLC
8 patents
- Vidaa (Netherland…
Vidaa (NETHERLANDS) International Holdings B.V. Vidaa
8 patents
- Video B Holdings
Video B Holdings Limited
8 patents
- Viewpoint
Viewpoint, Inc.
8 patents
- Virtamed
Virtamed AG
8 patents
- Viscofan
Viscofan, S.A.
8 patents
- Visibelle Derma I…
Visibelle Derma Institute, Inc.
8 patents
- Vision Motor Spor…
Vision Motor Sports, Inc.
8 patents
- Viiv Healthcare UK ◀
Viiv Healthcare UK Limited
8 patents
What this shows Viiv holds 8 patents at rank #33,777, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Viiv
By rank, the assignees closest to #33,777 in granted patent volume.
- Vibes Audio LLC #33,773 · 8 patents
- Vidaa (NETHERLANDS) International Holdings B.V. Vidaa #33,774 · 8 patents
- Video B Holdings Limited #33,775 · 8 patents
- Viewpoint, Inc. #33,776 · 8 patents
- Virtamed AG #33,778 · 8 patents
- Viscofan, S.A. #33,779 · 8 patents
- Visibelle Derma Institute, Inc. #33,780 · 8 patents
- Vision Motor Sports, Inc. #33,781 · 8 patents
Leaders in C07D (Heterocyclic Compounds)
Other assignees with the most granted patents in Viiv's primary technology class.
Viiv's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
20 7th percentile higher than 7% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 37.5% |
| 2016 | 1 | 12.5% |
| 2017 | 1 | 12.5% |
| 2018 | 2 | 25.0% |
| 2019 | 1 | 12.5% |
Which technologies does Viiv Healthcare UK Limited patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Viiv Healthcare UK Limited's patent record in context - here's where to go next.
- Viiv Healthcare UK Limited's lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
- Ranked #33,825 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Viiv Healthcare UK Limited against Vibes Audio LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 20.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.